The stock price of Alkermes plc (NASDAQ: ALKS) has jumped by 1.45 compared to previous close of 27.54. Despite this, the company has seen a fall of -0.89% in its stock price over the last five trading days. prnewswire.com reported 2025-04-02 that DUBLIN, April 2, 2025 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a webcast panel discussion “Development of Orexin Receptor Agonist in Sleep-Wake Disorders” at the upcoming 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9, 2025 at 11:45 a.m. EDT (4:45 p.m.
Is It Worth Investing in Alkermes plc (NASDAQ: ALKS) Right Now?
Alkermes plc (NASDAQ: ALKS) has a price-to-earnings ratio that is above its average at 12.82x. The stock has a 36-month beta value of 0.55. Opinions on the stock are mixed, with 8 analysts rating it as a “buy,” 2 as “overweight,” 6 as “hold,” and 0 as “sell.”
The public float for ALKS is 160.59M, and at present, short sellers hold a 6.85% of that float. On April 16, 2025, the average trading volume of ALKS was 1.80M shares.
ALKS’s Market Performance
ALKS stock saw a decrease of -0.89% in the past week, with a monthly decline of -18.71% and a quarterly a decrease of -1.96%. The volatility ratio for the week is 5.58%, and the volatility levels for the last 30 days are 4.08% for Alkermes plc (ALKS). The simple moving average for the last 20 days is -10.94% for ALKS’s stock, with a simple moving average of -4.47% for the last 200 days.
Analysts’ Opinion of ALKS
Many brokerage firms have already submitted their reports for ALKS stocks, with RBC Capital Mkts repeating the rating for ALKS by listing it as a “Sector Perform.” The predicted price for ALKS in the upcoming period, according to RBC Capital Mkts is $40 based on the research report published on March 13, 2025 of the current year 2025.
UBS, on the other hand, stated in their research note that they expect to see ALKS reach a price target of $38, previously predicting the price at $21. The rating they have provided for ALKS stocks is “Neutral” according to the report published on March 04th, 2025.
Deutsche Bank gave a rating of “Buy” to ALKS, setting the target price at $40 in the report published on February 11th of the current year.
ALKS Trading at -15.39% from the 50-Day Moving Average
After a stumble in the market that brought ALKS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -23.35% of loss for the given period.
Volatility was left at 4.08%, however, over the last 30 days, the volatility rate increased by 5.58%, as shares sank -18.71% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -9.17% lower at present.
During the last 5 trading sessions, ALKS fell by -0.89%, which changed the moving average for the period of 200-days by +15.03% in comparison to the 20-day moving average, which settled at $31.37. In addition, Alkermes plc saw -2.85% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ALKS starting from Parisi Samuel Joseph, who sale 1,938 shares at the price of $34.00 back on Feb 28 ’25. After this action, Parisi Samuel Joseph now owns 7,717 shares of Alkermes plc, valued at $65,892 using the latest closing price.
Parisi Samuel Joseph, the VP, Finance (Interim PAO) of Alkermes plc, sale 3,743 shares at $35.26 during a trade that took place back on Feb 25 ’25, which means that Parisi Samuel Joseph is holding 7,717 shares at $131,978 based on the most recent closing price.
Stock Fundamentals for ALKS
Current profitability levels for the company are sitting at:
- 0.27 for the present operating margin
- 0.84 for the gross margin
The net margin for Alkermes plc stands at 0.24. The total capital return value is set at 0.26. Equity return is now at value 27.90, with 17.76 for asset returns.
Based on Alkermes plc (ALKS), the company’s capital structure generated 0.05 points at debt to capital in total, while cash flow to debt ratio is standing at 5.81. The debt to equity ratio resting at 0.05. The interest coverage ratio of the stock is 18.63.
Currently, EBITDA for the company is 494.86 million with net debt to EBITDA at -0.44. When we switch over and look at the enterprise to sales, we see a ratio of 2.78. The receivables turnover for the company is 4.0for trailing twelve months and the total asset turnover is 0.76. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.04.
Conclusion
To sum up, Alkermes plc (ALKS) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
